Related to this topic: Equipment | Books | Your Experience | Other resources | Glossaries
Print options:
Other options:
(what's this?)
PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Infantile Intraventricular Haemorrhage
This is a significant cause of morbidity and mortality in infants who are born prematurely. Neurological complications include life-long problems such as seizures, developmental delay and cerebral palsy. IVH is uncommon in term infants, but can be seen in association with trauma and asphyxia. In these cases the bleeding is usually in the choroid plexus.
It is classified according to radiological appearance as follows:
|
Incidence
Occurs in 60-70% of neonates weighing 500-750g and 10-20% of those weighing 1,000-1500g.1 There is an inverse relationship between the severity of the haemorrhage and the likelihood of survival.
Risk Factors
- Prematurity; particularly <32 weeks
- Respiratory distress syndrome
- Hypoxia
- Sepsis
- Hypotension
- Hypovolaemia
- Hypertension
- Altered cerebral blood flow
Symptoms
Most cases present by third day of life; 50% on first day. 10-15% may show delayed haemorrhage occurring after first week.
Commonest symptoms are:
- Diminished/absent Moro reflex
- Poor muscle tone
- Sleepiness
- Lethargy
- Apnoea
Premature babies often show sudden deterioration on day 2 or 3 with periods of apnoea, pallor or cyanosis, failure to suck properly, abnormal eye signs, shrill cry, twitching or convulsions, reduced muscle tone or paralysis.
Signs
- Fontanelle may be tense and bulging with severe IVH.
- Neurological depression may progress to coma.
- In mild forms there may be no clinical signs, or there may be alternating symptomatic and asymptomatic periods.
- Apnoea of Prematurity
- Neonatal Sepsis
- Hypoglycaemia
- Hypermagnesaemia
- Periventricular Leukomalacia
- Arterial blood gases show metabolic acidosis
- Reduced haemoglobin level that may fail to improve on transfusion.
- Transfontanelle ultrasound; this is the diagnostic tool of choice. All premature babies at less than 30 weeks gestation have cranial ultrasound at 7-14 days of age.
This is mainly supportive and may include the correction of anaemia, acidosis, and hypotension. Ventilatory support may also be required for some who deteriorate acutely.
Non-Drug
- Packed red blood cells or fresh frozen plasma for anaemia and shock.
- Sodium bicarbonate infusion (carefully) for metabolic acidosis.
Drugs
- Anticonvulsants for seizures.
- Acetazolamide can be used to decrease cerebrospinal fluid production. 2This limits late, or rapidly progressive hydrocephalus.
Surgical
Ventriculoperitoneal and ventriculosubgaleal shunts are the definitive treatments for posthaemorrhagic hydrocephalus.
- 10-15% have hydrocephalus that may not appear for 2-4 weeks.
- Infants with massive haemorrhage often rapidly deteriorate and die.
- Significant proportion show motor and cognitive deficits.
- Extremely low birth weight infants with grades I-II IVH have poorer neurodevelopmental outcomes at 20 months' than infants with normal cranial ultrasound.3
- Antenatal steroids to mother4,5 and low dose indomethacin to infant. Indomethacin has been shown to decrease the risk of high-grade IVH, without improving developmental outcome.6
- Vitamin K. The Department of Health "recommends that all new-born babies are given vitamin K in the new-born period". Optimum timing and method of administration are unsure.
- Careful timing and management of delivery to avoid birth trauma and immaturity.7
Document References
- Koksal N, Baytan B, Bayram Y, et al; Risk factors for intraventricular haemorrhage in very low birth weight infants. Indian J Pediatr. 2002 Jul;69(7):561-4. [abstract]
- Poca MA, Sahuquillo J; Short-term medical management of hydrocephalus. Expert Opin Pharmacother. 2005 Aug;6(9):1525-38. [abstract]
- Patra K, Wilson-Costello D, Taylor HG, et al; Grades I-II intraventricular hemorrhage in extremely low birth weight infants: effects on neurodevelopment. J Pediatr. 2006 Aug;149(2):169-73. [abstract]
- Linder N, Haskin O, Levit O, et al; Risk factors for intraventricular hemorrhage in very low birth weight premature infants: a retrospective case-control study. Pediatrics. 2003 May;111(5 Pt 1):e590-5. [abstract]
- Ment LR, Oh W, Ehrenkranz RA, et al; Antenatal steroids, delivery mode, and intraventricular hemorrhage in preterm infants. Am J Obstet Gynecol. 1995 Mar;172(3):795-800. [abstract]
- Ment LR, Oh W, Ehrenkranz RA, et al; Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics. 1994 Apr;93(4):543-50. [abstract]
- Weintraub Z, Solovechick M, Reichman B, et al; Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2001 Jul;85(1):F13-7. [abstract]
Internet and Further Reading
- Nelson Textbook of Pediatrics. 16th Edition. Behrman RE et al. WB Saunder Co. 2000.
- Annibale DJ, Hill J. Periventricular Hemorrhage-Intraventricular Hemorrhage. e-Medicine; June 2006
DocID: 2319
Document Version: 20
DocRef: bgp446
Last Updated: 9 Apr 2007
Review Date: 8 Apr 2009
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicineOther - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
A-Z of UK Guidelines
A-Z of Online Videos
Medline
Other good health sites
Medical equipment products related to this topic (^ top of page)

Books related to this topic (^ top of page)

Want to search some more? Use the Google Search box below to search our site.

Would you like to try our advanced on-line knowledge support system designed to provide professionals with relevant up to date information about recognition and management of disease or take the Mentor Challenge?
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
